Cargando…
Glucagon-like peptide 1 improves insulin resistance in vitro through anti-inflammation of macrophages
Glucagon-like peptide 1 (GLP-1), a kind of gut hormone, is used in the treatment of type 2 diabetes (T2D). Emerging evidence indicates that GLP-1 has anti-inflammatory activity. Chronic inflammation in the adipose tissue of obese individuals is a cause of insulin resistance and T2D. We hypothesized...
Autores principales: | Guo, C., Huang, T., Chen, A., Chen, X., Wang, L., Shen, F., Gu, X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5188858/ https://www.ncbi.nlm.nih.gov/pubmed/27878229 http://dx.doi.org/10.1590/1414-431X20165826 |
Ejemplares similares
-
Kaempferol inhibited VEGF and PGF expression and in
vitro angiogenesis of HRECs under diabetic-like
environment
por: Xu, X.H., et al.
Publicado: (2017) -
Changes in cardiac aldosterone and its synthase in rats with chronic
heart failure: an intervention study of long-term treatment with recombinant human
brain natriuretic peptide
por: Zhu, X.Q., et al.
Publicado: (2014) -
In vitro proliferation and differentiation of hepatic oval cells and
their potential capacity for intrahepatic transplantation
por: Li, Z., et al.
Publicado: (2013) -
microRNA-142-3p inhibits apoptosis and inflammation induced by bleomycin through down-regulation of Cox-2 in MLE-12 cells
por: Guo, F., et al.
Publicado: (2017) -
Delivery of the Sox9 gene promotes chondrogenic
differentiation of human umbilical cord blood-derived mesenchymal stem cells in an
in vitro model
por: Wang, Z.H., et al.
Publicado: (2014)